As reported in our separate papers,1・2)we obtained the strain SK2-52 by protoplast fusion treatment between non-antibiotic-producing mutants of Streptomyces griseus and S.tenjimariensis and this produced a new antibiotic. In this communication the isolation characterization and structural elucidation of the antibiotic, indolizomycin are reported.